Palvella Therapeutics, Inc (PVLA) Stock Analysis

Palvella Therapeutics, Inc (PVLA) is a publicly traded company in the HEALTHCARE sector. It trades at $144.76, carries a market capitalization of $2.17B. This page summarizes the public market data, fundamentals, and frequently asked questions for PVLA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Price: $144.76
Market Cap: $2.17B
EPS: $-4.34
52-Week High: $161.38
52-Week Low: $25.80

Market Sentiment

Palvella Therapeutics, Inc currently has a Neutral sentiment score of 0.08.

About Palvella Therapeutics, Inc

None

GNG Research Analysis

GNG Research scores Palvella Therapeutics, Inc (PVLA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PVLA.

Frequently Asked Questions

Does PVLA pay dividends?

Palvella Therapeutics, Inc (PVLA) does not currently pay a regular dividend.

What is PVLA's market cap?

Palvella Therapeutics, Inc (PVLA) has a market capitalization of $2.17B with a current stock price of $144.76.